The U.S. Food and Drug Administration issued final guidance today entitled, “COVID-19: Master Protocols Evaluating Drugs and Biological Products for Treatment or Prevention Guidance for Industry.”
This guidance describes the FDA’s current recommendations to sponsors of master protocols evaluating drugs to treat or prevent COVID-19.
Read More
